|
1
|
Chang JJ and Lewin SR: Immunopathogenesis
of hepatitis B virus infection. Immunol Cell Biol. 85:16–23.
2007.PubMed/NCBI View Article : Google Scholar
|
|
2
|
European Association for the Study of the
Liver. Electronic address: simpleeasloffice@easloffice.eu;
European Association for the Study of the Liver. EASL 2017 Clinical
Practice Guidelines on the management of hepatitis B virus
infection. J Hepatol. 67:370–398. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Parrish-Novak J, Dillon SR, Nelson A,
Hammond A, Sprecher C, Gross JA, Johnston J, Madden K, Xu W, West
J, et al: Interleukin 21 and its receptor are involved in NK cell
expansion and regulation of lymphocyte function. Nature. 408:57–63.
2000.PubMed/NCBI View
Article : Google Scholar
|
|
4
|
Bryant VL, Ma CS, Avery DT, Li Y, Good KL,
Corcoran LM, de Waal Malefyt R and Tangye SG: Cytokine-mediated
regulation of human B cell differentiation into Ig-secreting cells:
Predominant role of IL-21 produced by CXCR5+ T follicular helper
cells. J Immunol. 179:8180–8190. 2007.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Wei L, Laurence A, Elias KM and O'Shea JJ:
IL-21 is produced by Th17 cells and drives IL-17 production in a
STAT3-dependent manner. J Biol Chem. 282:34605–34610.
2007.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Coquet JM, Kyparissoudis K, Pellicci DG,
Besra G, Berzins SP, Smyth MJ and Godfrey DI: IL-21 is produced by
NKT cells and modulates NKT cell activation and cytokine
production. J Immunol. 178:2827–2834. 2007.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Spolski R and Leonard WJ: Interleukin-21:
Basic biology and implications for cancer and autoimmunity. Annu
Rev Immunol. 26:57–79. 2008.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Mantellone G, Pallone F and Macdonald TT:
Interleukin-21 as a new therapeutic target for immune-mediated
diseases. Trends Pharmacol Sci. 30:441–447. 2009.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Li HJ, Kang FB, Li BS, Yang XY, Zhang YG
and Sun DX: Interleukin-21 inhibits HBV replication in vitro.
Antivir Ther. 20:583–590. 2015.PubMed/NCBI View
Article : Google Scholar
|
|
10
|
Zhong H, Xibing G, Yaping D, Zheng W,
Decai F, Xiaoye G, Hangyuan W, Dong W and Zhonghua L: Interleukin-7
in patients with chronic hepatitis B may have effect on T
follicular helper cells and specific cellular immunity. Hepat Mon.
16(e36068)2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Li L, Liu M, Cheng LW, Gao XY, Fu JJ, Kong
G, Feng X and Pan XC: HBcAg-specific IL-21-producing CD4+ T cells
are associated with relative viral control in patients with chronic
hepatitis B. Scand J Immunol. 78:439–446. 2013.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Ma SW, Huang X, Li YY, Tang LB, Sun XF,
Jiang XT, Zhang YX, Sun J, Liu ZH, Abbott WG, et al: High serum
IL-21 levels after 12 weeks of antiviral therapy predict HBeAg
seroconversion in chronic hepatitis B. J Hepatol. 56:775–781.
2012.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Publicover J, Goodsell A, Nishimura S,
Vilarinho S, Wang ZE, Avanesyan L, Spolski R, Leonard WJ, Cooper S
and Baron JL: IL-21 is pivotal in determining age-dependent
effectiveness of immune responses in a mouse model of human
hepatitis B. J Clin Invest. 121:1154–1162. 2011.PubMed/NCBI View
Article : Google Scholar
|
|
14
|
Li Y, Ma S, Tang L, Li Y, Wang W, Huang X,
Lai Q, Zhang M, Sun J, Li CK, et al: Circulating chemokine (C-X-C
Motif) receptor 5(+) CD4(+) T cells benefit hepatitis B e antigen
seroconversion through IL-21 in patients with chronic hepatitis B
virus infection. Hepatology. 58:1277–286. 2013.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Wu X, Su Z, Cai B, Yan L, Li Y, Feng W and
Wang L: Increased circulating follicular regulatory T-like cells
may play a critical role in chronic hepatitis B virus infection and
disease progression. Viral Immunol. 31:379–388. 2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Chen HM, Liu HL, Yang YC, Cheng XL, Wang
YF, Xing FF and Zhao YR: Serum IL-21 levels associated with chronic
hepatitis B and hepatitis B-related liver failure. Exp Ther Med.
7:1013–1019. 2014.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Vyas AK, Sharma BC, Sarin SK and
Trehanpati N: Immune correlates of hepatitis B surface antigen
spontaneous seroconversion in hepatitis B e antigen negative
chronic hepatitis B patients. Liver Int. 38:38–49. 2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Liu X, Shen Z, Zhang H, Liang J and Lin H:
Interleukin-21 is associated with early antiviral response in
patients with hepatitis B e antigen-positive chronic hepatitis B
and nonalcoholic fatty liver disease. J Interferon Cytokine Res.
36:367–373. 2016.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Lai CL, Gane E, Liaw YF, Hsu CW,
Thongsawat S, Wang Y, Chen Y, Heathcote EJ, Rasenack J, Bzowej N,
et al: Telbivudine versus lamivudine in patients with chronic
hepatitis B. N Engl J Med. 357:2576–2588. 2007.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Wu JF, Wu TC, Chen CH, Ni YH, Chen HL, Hsu
HY and Chang MH: Serum levels of interleukin-10 and interleukin-12
predict early, spontaneous hepatitis B virus e antigen
seroconversion. Gastroenterology. 138:165–172.e1-e3.
2010.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Giarda P, Avihingsanon A, Sasadeusz J,
Audsley J, Marks P, Matthews G, Ruxrungtham K, Lewin SR and Crane
M: CXCL-10, interleukin-12 and interleukin-21 are not immunological
predictors of HBeAg seroconversion in HIV-1-HBV coinfection
following HBV-active antiretroviral therapy. Antivir Ther.
19:429–433. 2014.PubMed/NCBI View
Article : Google Scholar
|
|
22
|
Li J, Ren W, Ma W, Zhang J, Shi J and Qin
C: Interleukin-21 responses in patients with chronic hepatitis B. J
Interferon Cytokine Res. 35:134–142. 2015.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Crotty S: Follicular helper CD4 T cells
(Tfh). Annu Rev Immunol. 29:621–663. 2011.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Ozaki K, Spolski R, Feng CG, Qi CF, Cheng
J, Sher A, Morse HC III, Liu C, Schwartzberg PL and Leonard WJ: A
critical role for IL-21 in regulating immunoglobulin production.
Science. 298:1630–1634. 2002.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Hu TT, Song XF, Lei Y, Hu HD, Ren H and Hu
P: Expansion of circulating TFH cells and their associated
molecules: Involvement in the immune landscape in patients with
chronic HBV infection. Virol J. 11(54)2014.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Pan Q, Yu Y, Tang Z, Xi M, Jiang H, Xun Y,
Liu X, Liu H, Hu J and Zang G: Increased levels of IL-21 responses
are associated with the severity of liver injury in patients with
chronic active hepatitis B. J Viral Hepat. 21:e78–e88.
2014.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Xing T, Xu H and Yu W: Role of T
follicular helper cells and their associated molecules in the
pathogenesis of chronic hepatitis B virus infection. Exp Ther Med.
5:885–889. 2013.PubMed/NCBI View Article : Google Scholar
|
